CD8A and COVID-19: This study revealed significant differences in the bone marrow CD8 concentrations of COVID-19 convalescent patients compared to controls, with increased TBRs in the first 7 hours of the study and increased net influx rates (2T5P Ki) observed in the bone marrow of COVID-19 convalescent patients.